| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | leukemia inhibitory factor receptor activity | 6.95e-05 | 2 | 167 | 2 | GO:0004923 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | FLII ADAP1 OBSCN GRB7 SYT7 ITPR3 ARAP3 PIK3C2B SVIL SYT1 AKT1 | 7.40e-05 | 316 | 167 | 11 | GO:0035091 |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 2.02e-04 | 35 | 167 | 4 | GO:0043325 | |
| GeneOntologyMolecularFunction | oncostatin-M receptor activity | 2.07e-04 | 3 | 167 | 2 | GO:0004924 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate binding | 2.77e-04 | 199 | 167 | 8 | GO:1901981 | |
| GeneOntologyMolecularFunction | ciliary neurotrophic factor receptor activity | 4.13e-04 | 4 | 167 | 2 | GO:0004897 | |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate binding | 5.44e-04 | 121 | 167 | 6 | GO:1902936 | |
| GeneOntologyMolecularFunction | pheromone binding | 6.84e-04 | 5 | 167 | 2 | GO:0005550 | |
| GeneOntologyMolecularFunction | inositol 1,3,4,5 tetrakisphosphate binding | 6.84e-04 | 5 | 167 | 2 | GO:0043533 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4,5-trisphosphate binding | 7.46e-04 | 49 | 167 | 4 | GO:0005547 | |
| GeneOntologyMolecularFunction | protein-cysteine S-myristoyltransferase activity | 1.02e-03 | 6 | 167 | 2 | GO:0019705 | |
| GeneOntologyMolecularFunction | neuregulin binding | 1.02e-03 | 6 | 167 | 2 | GO:0038132 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.05e-03 | 188 | 167 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate binding | 1.22e-03 | 95 | 167 | 5 | GO:0005546 | |
| GeneOntologyMolecularFunction | ciliary neurotrophic factor receptor binding | 1.42e-03 | 7 | 167 | 2 | GO:0005127 | |
| GeneOntologyMolecularFunction | protein-cysteine S-stearoyltransferase activity | 1.42e-03 | 7 | 167 | 2 | GO:0140439 | |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 1.45e-03 | 27 | 167 | 3 | GO:0017134 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 5.99e-08 | 44 | 167 | 7 | GO:0048026 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 1.30e-07 | 49 | 167 | 7 | GO:0050685 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 7.60e-07 | 63 | 167 | 7 | GO:0033120 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 1.04e-05 | 129 | 167 | 8 | GO:0048024 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 4.49e-05 | 158 | 167 | 8 | GO:0050684 | |
| GeneOntologyBiologicalProcess | wound healing | DGKZ ST3GAL4 ENPP4 ITGAV SYT7 JAK2 THBS1 SLC11A1 NFATC1 SYK FGG PLEK ALOX5 IL6ST | 5.06e-05 | 493 | 167 | 14 | GO:0042060 |
| GeneOntologyBiologicalProcess | hemostasis | 6.86e-05 | 268 | 167 | 10 | GO:0007599 | |
| GeneOntologyBiologicalProcess | protein autophosphorylation | 1.04e-04 | 228 | 167 | 9 | GO:0046777 | |
| GeneOntologyCellularComponent | spliceosomal complex | SF3B4 RBMY1A1 RBMY1C DDX42 RBMY1D RBMY1B RBMY1E RBMY1F RBM41 | 5.99e-05 | 215 | 167 | 9 | GO:0005681 |
| GeneOntologyCellularComponent | anchoring junction | FLII CDHR2 GJB4 ASH1L OBSCN APC LAMA3 GRB7 ITGA6 LASP1 ITGAV JAK2 FZD5 SVIL NECTIN2 AKT1 KIFC3 FLRT1 FYB1 CDH9 | 1.07e-04 | 976 | 167 | 20 | GO:0070161 |
| Domain | RBM1CTR | 2.86e-09 | 8 | 166 | 5 | PF08081 | |
| Domain | RBM1CTR | 2.86e-09 | 8 | 166 | 5 | IPR012604 | |
| Domain | RRM | 1.43e-04 | 217 | 166 | 9 | SM00360 | |
| Domain | Laminin_G | 1.64e-04 | 58 | 166 | 5 | IPR001791 | |
| Domain | PH | ADAP1 OBSCN GRB7 SYNGAP1 ARHGEF40 ARAP3 ELMO2 AKT1 PLEK ACAP3 | 1.97e-04 | 278 | 166 | 10 | SM00233 |
| Domain | RRM_dom | 2.01e-04 | 227 | 166 | 9 | IPR000504 | |
| Domain | PH_DOMAIN | ADAP1 OBSCN GRB7 SYNGAP1 ARHGEF40 ARAP3 ELMO2 AKT1 PLEK ACAP3 | 2.02e-04 | 279 | 166 | 10 | PS50003 |
| Domain | PH_domain | ADAP1 OBSCN GRB7 SYNGAP1 ARHGEF40 ARAP3 ELMO2 AKT1 PLEK ACAP3 | 2.08e-04 | 280 | 166 | 10 | IPR001849 |
| Domain | RRM | 2.21e-04 | 230 | 166 | 9 | PS50102 | |
| Domain | von_Ebner_gland | 2.34e-04 | 3 | 166 | 2 | IPR002450 | |
| Domain | LIPOCALIN | 4.28e-04 | 17 | 166 | 3 | PS00213 | |
| Domain | HoxA13_N | 4.66e-04 | 4 | 166 | 2 | PF12284 | |
| Domain | HoxA13_N | 4.66e-04 | 4 | 166 | 2 | IPR022067 | |
| Domain | Lipocalin | 5.10e-04 | 18 | 166 | 3 | IPR002345 | |
| Domain | Nucleotide-bd_a/b_plait | 5.13e-04 | 258 | 166 | 9 | IPR012677 | |
| Domain | RRM_1 | 5.55e-04 | 208 | 166 | 8 | PF00076 | |
| Domain | Laminin_domII | 7.72e-04 | 5 | 166 | 2 | IPR010307 | |
| Domain | Laminin_aI | 7.72e-04 | 5 | 166 | 2 | IPR009254 | |
| Domain | Laminin_I | 7.72e-04 | 5 | 166 | 2 | PF06008 | |
| Domain | Laminin_II | 7.72e-04 | 5 | 166 | 2 | PF06009 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.90e-05 | 66 | 128 | 6 | M18 | |
| Pathway | REACTOME_HEMOSTASIS | GRB7 ITGA6 DGKZ ITGAV ITPR3 JAK2 PPP2CA PPP2CB THBS1 SYK AKT1 AKAP10 FGG PLEK ATP2B4 KLC1 | 5.92e-05 | 571 | 128 | 16 | MM14472 |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | ADAP1 LAMA2 LAMA3 GRB7 ITGAV RIT2 ITPR3 JAK2 PPP2CA PPP2CB THBS1 ELMO2 AKT1 FLRT1 KLB | 9.56e-05 | 532 | 128 | 15 | M27870 |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.14e-04 | 11 | 128 | 3 | M158 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.48e-04 | 30 | 128 | 4 | M27216 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 1.69e-04 | 31 | 128 | 4 | M27400 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 1.69e-04 | 31 | 128 | 4 | MM15154 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.93e-04 | 59 | 128 | 5 | M27218 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 2.16e-04 | 33 | 128 | 4 | M39503 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 2.44e-04 | 34 | 128 | 4 | M27405 | |
| Pubmed | 8.39e-14 | 7 | 169 | 6 | 8269511 | ||
| Pubmed | 1.09e-11 | 12 | 169 | 6 | 9598316 | ||
| Pubmed | 1.53e-11 | 6 | 169 | 5 | 15184870 | ||
| Pubmed | Degeneracy in human multicopy RBM (YRRM), a candidate spermatogenesis gene. | 5.32e-11 | 7 | 169 | 5 | 8875892 | |
| Pubmed | An RBM homologue maps to the mouse Y chromosome and is expressed in germ cells. | 2.68e-09 | 5 | 169 | 4 | 8817321 | |
| Pubmed | 2.68e-09 | 5 | 169 | 4 | 20016065 | ||
| Pubmed | The role of human and mouse Y chromosome genes in male infertility. | 2.68e-09 | 5 | 169 | 4 | 11097427 | |
| Pubmed | Rapid evolution of mouse Y centromere repeat DNA belies recent sequence stability. | 2.68e-09 | 5 | 169 | 4 | 19737860 | |
| Pubmed | Meiotic sex chromosome inactivation in male mice with targeted disruptions of Xist. | 8.01e-09 | 6 | 169 | 4 | 12356914 | |
| Pubmed | 8.01e-09 | 6 | 169 | 4 | 9499427 | ||
| Pubmed | 8.01e-09 | 6 | 169 | 4 | 15051956 | ||
| Pubmed | Identification of target messenger RNA substrates for mouse RBMY. | 8.01e-09 | 6 | 169 | 4 | 18492746 | |
| Pubmed | 8.01e-09 | 6 | 169 | 4 | 18239052 | ||
| Pubmed | The roles of RNA-binding proteins in spermatogenesis and male infertility. | 1.86e-08 | 7 | 169 | 4 | 10377282 | |
| Pubmed | 1.86e-08 | 7 | 169 | 4 | 17001072 | ||
| Pubmed | 3.71e-08 | 8 | 169 | 4 | 7479793 | ||
| Pubmed | 1.10e-07 | 10 | 169 | 4 | 10601091 | ||
| Pubmed | 1.10e-07 | 10 | 169 | 4 | 9384609 | ||
| Pubmed | 1.13e-07 | 3 | 169 | 3 | 22837212 | ||
| Pubmed | The role of Dby mRNA in early development of male mouse zygotes. | 2.58e-07 | 12 | 169 | 4 | 20543856 | |
| Pubmed | MAK CDHR2 TMEM126B VSIG4 APC ST3GAL4 ADCY7 STK16 LIFR ATXN1 TMEM106C VCAN RECQL5 RCOR3 AKAP10 TOMM40 CSNK1G2-AS1 GAPDHS FYB1 ANO3 GOLGB1 KLC1 | 3.54e-07 | 1293 | 169 | 22 | 15342556 | |
| Pubmed | GASZ promotes germ cell derivation from embryonic stem cells. | 3.72e-07 | 13 | 169 | 4 | 23816659 | |
| Pubmed | 3.72e-07 | 13 | 169 | 4 | 10749975 | ||
| Pubmed | PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. | 4.49e-07 | 4 | 169 | 3 | 21030605 | |
| Pubmed | 4.49e-07 | 4 | 169 | 3 | 29038846 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLII OBSCN ZDHHC7 ADCY7 ITPR3 JAK2 ZGPAT PPP2CB ARHGEF40 ARAP3 PNPLA6 NFATC1 PIK3C2B DIP2C LRP4 AKT1 KIFC3 SSBP4 ALOX5 HOXB13 | 4.86e-07 | 1105 | 169 | 20 | 35748872 |
| Pubmed | Absence of mDazl produces a final block on germ cell development at meiosis. | 5.19e-07 | 14 | 169 | 4 | 14611631 | |
| Pubmed | Evolutionary strata on the mouse X chromosome correspond to strata on the human X chromosome. | 7.04e-07 | 15 | 169 | 4 | 14762062 | |
| Pubmed | Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations. | 1.12e-06 | 5 | 169 | 3 | 30622113 | |
| Pubmed | Loss of maternal Trim28 causes male-predominant early embryonic lethality. | 1.22e-06 | 17 | 169 | 4 | 28115466 | |
| Pubmed | CYLD FBXW12 DDX42 ASH1L OBSCN APC DGKZ PYM1 ZDHHC17 ME2 MAP3K3 ALDH1L2 TMEM106C SIPA1L1 VCAN SYT1 RCOR3 ATP11A GOLGB1 | 1.54e-06 | 1084 | 169 | 19 | 11544199 | |
| Pubmed | Sex differences in sex chromosome gene expression in mouse brain. | 1.56e-06 | 18 | 169 | 4 | 12023983 | |
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 23565137 | ||
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 31145836 | ||
| Pubmed | 3.89e-06 | 7 | 169 | 3 | 10698523 | ||
| Pubmed | 6.20e-06 | 8 | 169 | 3 | 23462102 | ||
| Pubmed | CYLD FLI1 SIN3B RTCB STRBP MSANTD2 LASP1 TRIM24 SCAF4 PPP2CA SALL2 NKX2-4 ATXN1 GLO1 MORF4L1 RECQL5 SVIL RBM6 RCOR3 SSBP4 SORL1 | 6.60e-06 | 1429 | 169 | 21 | 35140242 | |
| Pubmed | 7.33e-06 | 203 | 169 | 8 | 19953087 | ||
| Pubmed | 7.40e-06 | 26 | 169 | 4 | 35920200 | ||
| Pubmed | Genetics of shoulder girdle formation: roles of Tbx15 and aristaless-like genes. | 9.27e-06 | 9 | 169 | 3 | 15728667 | |
| Pubmed | 1.20e-05 | 156 | 169 | 7 | 29961565 | ||
| Pubmed | Integrin repertoire on myogenic cells changes during the course of primary myogenesis in the mouse. | 1.81e-05 | 11 | 169 | 3 | 15739233 | |
| Pubmed | CYLD FLII SIN3B APC MSANTD2 DGKZ ARHGAP39 SYNGAP1 PPP2CB SIPA1L1 MORF4L1 SVIL SYT1 ATP2B4 GOLGB1 KLC1 | 2.07e-05 | 963 | 169 | 16 | 28671696 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CYLD SF3B4 RTCB APC MAP3K3 VPS13D ATXN1 PIK3C2B ELMO2 AASS SIPA1L1 SVIL NECTIN2 GOLGB1 KLC1 | 2.20e-05 | 861 | 169 | 15 | 36931259 |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23415882 | ||
| Pubmed | TMEM16C is involved in thermoregulation and protects rodent pups from febrile seizures. | 2.35e-05 | 2 | 169 | 2 | 33972431 | |
| Pubmed | CR3 Engaged by PGL-I Triggers Syk-Calcineurin-NFATc to Rewire the Innate Immune Response in Leprosy. | 2.35e-05 | 2 | 169 | 2 | 31921172 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 39178518 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24486434 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 30827841 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 30827843 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 16478297 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 11751260 | ||
| Pubmed | Membrane-Binding Cooperativity and Coinsertion by C2AB Tandem Domains of Synaptotagmins 1 and 7. | 2.35e-05 | 2 | 169 | 2 | 30795874 | |
| Pubmed | Effect of Recql5 deficiency on the intestinal tumor susceptibility of Apc(min) mice. | 2.35e-05 | 2 | 169 | 2 | 20333788 | |
| Pubmed | Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. | 2.35e-05 | 2 | 169 | 2 | 12741986 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 35093267 | ||
| Pubmed | Early changes of LIFR and gp130 in sciatic nerve and muscle of diabetic mice. | 2.35e-05 | 2 | 169 | 2 | 21565387 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28978472 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12584168 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 29339153 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22592401 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 8939648 | ||
| Pubmed | Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. | 2.35e-05 | 2 | 169 | 2 | 1915266 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 12044155 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 32107949 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 10543450 | ||
| Pubmed | Selective modulation of subtype III IP₃R by Akt regulates ER Ca²⁺ release and apoptosis. | 2.35e-05 | 2 | 169 | 2 | 22552281 | |
| Pubmed | Genetic deletion of 5-lipoxygenase increases tumor-infiltrating macrophages in Apc(Δ468) mice. | 2.35e-05 | 2 | 169 | 2 | 22072302 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 28089901 | ||
| Pubmed | Structure and transcriptional regulation of protein phosphatase 2A catalytic subunit genes. | 2.35e-05 | 2 | 169 | 2 | 1846293 | |
| Pubmed | PP2A regulates kinetochore-microtubule attachment during meiosis I in oocyte. | 2.35e-05 | 2 | 169 | 2 | 27096707 | |
| Pubmed | Synaptotagmins 1 and 7 in vesicle release from rods of mouse retina. | 2.35e-05 | 2 | 169 | 2 | 36280223 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 26033700 | ||
| Pubmed | Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A. | 2.35e-05 | 2 | 169 | 2 | 2555176 | |
| Pubmed | The primed SNARE-complexin-synaptotagmin complex for neuronal exocytosis. | 2.35e-05 | 2 | 169 | 2 | 28813412 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 21659549 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 11839802 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 18308932 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 25348485 | ||
| Pubmed | Structural and mutational analysis of functional differentiation between synaptotagmins-1 and -7. | 2.35e-05 | 2 | 169 | 2 | 20824061 | |
| Pubmed | Differential Membrane Binding Mechanics of Synaptotagmin Isoforms Observed in Atomic Detail. | 2.35e-05 | 2 | 169 | 2 | 27997124 | |
| Pubmed | PDZK1: II. an anchoring site for the PKA-binding protein D-AKAP2 in renal proximal tubular cells. | 2.35e-05 | 2 | 169 | 2 | 14531807 | |
| Pubmed | Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. | 2.35e-05 | 2 | 169 | 2 | 16227992 | |
| Pubmed | Determinants for the interaction between Janus kinase 2 and protein phosphatase 2A. | 2.35e-05 | 2 | 169 | 2 | 12921784 | |
| Pubmed | Mast cell 5-lipoxygenase activity promotes intestinal polyposis in APCDelta468 mice. | 2.35e-05 | 2 | 169 | 2 | 21216893 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 10607840 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23926298 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 24267651 | ||
| Pubmed | Hoxb13 is required for normal differentiation and secretory function of the ventral prostate. | 2.35e-05 | 2 | 169 | 2 | 12668621 | |
| Pubmed | A molecular pathogenesis for transcription factor associated poly-alanine tract expansions. | 2.35e-05 | 2 | 169 | 2 | 15333588 | |
| Pubmed | MRG15 activates histone methyltransferase activity of ASH1L by recruiting it to the nucleosomes. | 2.35e-05 | 2 | 169 | 2 | 37527654 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 19500214 | ||
| Pubmed | Promoter hypomethylated PDZK1 acts as a tumorigenic gene in glioma by interacting with AKT1. | 2.35e-05 | 2 | 169 | 2 | 38669103 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 23300340 | ||
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 11113010 | ||
| Pubmed | Synaptotagmins 1 and 7 Play Complementary Roles in Somatodendritic Dopamine Release. | 2.35e-05 | 2 | 169 | 2 | 35361702 | |
| Pubmed | Potential dual functional roles of the Y-linked RBMY in hepatocarcinogenesis. | 2.35e-05 | 2 | 169 | 2 | 32473614 | |
| Pubmed | 2.35e-05 | 2 | 169 | 2 | 22966849 | ||
| Pubmed | Epigenetic silencing of novel tumor suppressors in malignant melanoma. | 2.35e-05 | 2 | 169 | 2 | 17145863 | |
| Cytoband | Yq11.223 | 2.55e-05 | 93 | 169 | 5 | Yq11.223 | |
| Cytoband | 15q24 | 6.21e-05 | 21 | 169 | 3 | 15q24 | |
| GeneFamily | RNA binding motif containing | SF3B4 RBMY1A1 RBMY1C RBMY1D RBMY1B RBMY1E SCAF4 RBMY1F RBM6 RBM41 | 3.25e-06 | 213 | 130 | 10 | 725 |
| GeneFamily | Lipocalins | 3.24e-04 | 19 | 130 | 3 | 631 | |
| GeneFamily | Gelsolin/villins | 1.40e-03 | 8 | 130 | 2 | 950 | |
| GeneFamily | ArfGAPs | 1.69e-03 | 33 | 130 | 3 | 395 | |
| GeneFamily | Doublecortin superfamily | 2.22e-03 | 10 | 130 | 2 | 1369 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 3.23e-03 | 12 | 130 | 2 | 1243 | |
| GeneFamily | Laminin subunits | 3.23e-03 | 12 | 130 | 2 | 626 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.77e-03 | 206 | 130 | 6 | 682 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 3.80e-03 | 13 | 130 | 2 | 693 | |
| Coexpression | PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP | QTRT2 LIFR THBS1 FZD5 SIPA1L1 VCAN UGDH ATP11A PLEK UBE2W IL6ST | 3.02e-06 | 291 | 168 | 11 | M41002 |
| Coexpression | GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP | 9.41e-06 | 160 | 168 | 8 | M339 | |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | THSD4 FLII VSIG4 LAMA3 ITGA6 ZDHHC7 LASP1 ITGAV THBS1 ARHGEF40 FZD5 GLO1 SIPA1L1 SVIL NECTIN2 SYK ATP11A FYB1 ATP2B4 ALOX5 IL6ST VAT1 | 2.36e-05 | 1276 | 168 | 22 | M39173 |
| Coexpression | LIU_SOX4_TARGETS_UP | 3.29e-05 | 139 | 168 | 7 | M17450 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | SIN3B ADAP1 STRBP OBSCN ARHGAP39 PNPLA6 RECQL5 DIP2C SYT1 RSPH9 ACAP3 | 4.51e-05 | 389 | 168 | 11 | M39102 |
| Coexpression | GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN | 4.52e-05 | 199 | 168 | 8 | M7374 | |
| Coexpression | GSE360_DC_VS_MAC_T_GONDII_DN | 4.52e-05 | 199 | 168 | 8 | M5184 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP | 4.68e-05 | 200 | 168 | 8 | M5973 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN | 4.68e-05 | 200 | 168 | 8 | M9688 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP | 4.68e-05 | 200 | 168 | 8 | M6524 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP | 4.68e-05 | 200 | 168 | 8 | M5416 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN | 4.86e-05 | 260 | 168 | 9 | M41075 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 5.76e-05 | 33 | 168 | 4 | MM701 | |
| Coexpression | BHAT_ESR1_TARGETS_VIA_AKT1_UP | 8.81e-05 | 281 | 168 | 9 | M2234 | |
| Coexpression | THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN | 1.13e-04 | 227 | 168 | 8 | M11234 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | OBP2A FBXW12 PRSS12 RBMY1A1 RBMY1D RBMY1B RBMY1E ITGA6 PTGDS PNPLA6 TMEM106C DIP2C HEPHL1 | 1.39e-04 | 600 | 168 | 13 | MM1025 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | THSD4 OBP2A CDHR2 RBMY1A1 DDX42 OBSCN RBMY1D RBMY1B RBMY1E OR8K3 POLR3A ARAP3 HOXD13 RBMY1F GAPDHS FYB1 | 1.65e-04 | 873 | 168 | 16 | M16009 |
| Coexpression | GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP | 1.73e-04 | 181 | 168 | 7 | M6814 | |
| Coexpression | ZHENG_IL22_SIGNALING_DN | 1.98e-04 | 45 | 168 | 4 | MM763 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 2.50e-04 | 323 | 168 | 9 | M9150 | |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3 | GJB4 PYROXD2 LAMA2 GRB7 SCML4 LIFR NSUN6 SLC11A1 AASS RECQL5 SYT1 FLRT1 FAIM2 RBM41 | 2.63e-04 | 728 | 168 | 14 | M2004 |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 2.64e-04 | 194 | 168 | 7 | M7306 | |
| Coexpression | BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP | 2.72e-04 | 20 | 168 | 3 | M45002 | |
| Coexpression | BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP | 2.72e-04 | 20 | 168 | 3 | MM1336 | |
| Coexpression | GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_UP | 2.81e-04 | 196 | 168 | 7 | M7616 | |
| Coexpression | GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP | 2.90e-04 | 197 | 168 | 7 | M8983 | |
| Coexpression | GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP | 2.99e-04 | 198 | 168 | 7 | M8370 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP | 3.09e-04 | 199 | 168 | 7 | M4526 | |
| Coexpression | GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP | 3.09e-04 | 199 | 168 | 7 | M313 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN | 3.09e-04 | 199 | 168 | 7 | M8313 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP | 3.09e-04 | 199 | 168 | 7 | M7414 | |
| Coexpression | GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP | 3.09e-04 | 199 | 168 | 7 | M3084 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | MGAM FAT4 COL19A1 CDHR2 VSIG4 ZDHHC7 CACHD1 ARAP3 SLC11A1 VCAN SYK ALOX5 VAT1 SORL1 | 3.10e-04 | 740 | 168 | 14 | M41202 |
| Coexpression | SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A | 3.16e-04 | 21 | 168 | 3 | M1501 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN | 3.18e-04 | 200 | 168 | 7 | M5980 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP | 3.18e-04 | 200 | 168 | 7 | M7294 | |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN | 3.18e-04 | 200 | 168 | 7 | M8635 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP | 3.18e-04 | 200 | 168 | 7 | M3780 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_UP | 3.18e-04 | 200 | 168 | 7 | M4948 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP | 3.18e-04 | 200 | 168 | 7 | M4966 | |
| Coexpression | GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN | 3.18e-04 | 200 | 168 | 7 | M7502 | |
| Coexpression | GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP | 3.18e-04 | 200 | 168 | 7 | M6437 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP | 3.18e-04 | 200 | 168 | 7 | M8954 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP | 3.18e-04 | 200 | 168 | 7 | M5229 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 3.18e-04 | 200 | 168 | 7 | M6513 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP | 3.18e-04 | 200 | 168 | 7 | M5418 | |
| Coexpression | GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP | 3.18e-04 | 200 | 168 | 7 | M4323 | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | FLI1 VSIG4 THBS1 SLC11A1 SIPA1L1 SYK MED12L SYT1 PLEK FYB1 ALOX5 | 1.61e-10 | 191 | 166 | 11 | e7a0bc46ba9ba772636a583f3387748418e18832 |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 2.95e-09 | 192 | 166 | 10 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 3.26e-09 | 194 | 166 | 10 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 4.83e-08 | 193 | 166 | 9 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 5.28e-08 | 195 | 166 | 9 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 5.52e-08 | 196 | 166 | 9 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.76e-08 | 197 | 166 | 9 | 33f2fe101ae5744eea3915add37e60aa398bb97f | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.76e-08 | 197 | 166 | 9 | 9262785807faeb32417fad7ef202405053e453e2 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.76e-08 | 197 | 166 | 9 | d8ef5cb88dd66e112cb94217b9ad5cd70164f1d0 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.76e-08 | 197 | 166 | 9 | 5e9a3932ae5147a3d73dc70f1545926a692930ed | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM2|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.76e-08 | 197 | 166 | 9 | 8a126cfe1529f3d75a806aa492743314a8a43ef9 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.02e-08 | 198 | 166 | 9 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | COVID-19-kidney-Macrophages|kidney / Disease (COVID-19 only), tissue and cell type | 6.02e-08 | 198 | 166 | 9 | 161324541fe5da5cbb58142ea94fefd39b7dfb04 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-07 | 162 | 166 | 8 | 484ea4ac40de672dcbd2583a52cb7f385c918814 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-07 | 162 | 166 | 8 | bba144ac5332bab9eba2ccf599703c781a7f88f1 | |
| ToppCell | (1)_T_CD4_naive|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 5.49e-07 | 188 | 166 | 8 | b8f67ac2faadd5b848955e43ab5d6cf5e49b3681 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 5.95e-07 | 190 | 166 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 6.44e-07 | 192 | 166 | 8 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.24e-07 | 195 | 166 | 8 | ae98215b7b7f22f1aca690920ce6092dc4a3c7db | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.24e-07 | 195 | 166 | 8 | 6fcab7aa4db958ccad0300adea9aaae52ace5bff | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.24e-07 | 195 | 166 | 8 | 7b6c69df943842b566a596e30bb50dbe80dccc83 | |
| ToppCell | Adult-Immune-monocyte|Adult / Lineage, Cell type, age group and donor | 7.53e-07 | 196 | 166 | 8 | 3ef193c5180de3137daf886492e74fc574bc9767 | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 7.53e-07 | 196 | 166 | 8 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.53e-07 | 196 | 166 | 8 | 291c59b609985167c98a40d4e2caeea2fad74941 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 7.82e-07 | 197 | 166 | 8 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 7.82e-07 | 197 | 166 | 8 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 8.12e-07 | 198 | 166 | 8 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.12e-07 | 198 | 166 | 8 | d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.12e-07 | 198 | 166 | 8 | 96883ad8e189a46ed5b7eaafc0543e53682d26ed | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.12e-07 | 198 | 166 | 8 | c4a004f211f72f28aacbb512c6e075cbd049be53 | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 8.12e-07 | 198 | 166 | 8 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.44e-07 | 199 | 166 | 8 | 04adf46975aa4194ea40c7480f8a517def5d929c | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells-Neutrophils|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.44e-07 | 199 | 166 | 8 | 8c2ab13b5fffbab3da37041a7000d6537fc4db09 | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 8.44e-07 | 199 | 166 | 8 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Myeloid-Granulocytic_cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.76e-07 | 200 | 166 | 8 | 1592ca96c59eb053d0f0915afb337db9f3a40c91 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 159 | 166 | 7 | baf843dc44b072504eb1d28de55b1ee67aeec32b | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-06 | 159 | 166 | 7 | 9eb78202b9a4e8217f00e64d5142ed28c00abd04 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-06 | 160 | 166 | 7 | 2020b6defbaf5b5db12af37f0103ac028a8ca76e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-06 | 160 | 166 | 7 | af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-06 | 162 | 166 | 7 | ad974426039f4952c59d27167eac24dc6ce63f5e | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-neutrophil-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-06 | 162 | 166 | 7 | 4e7e565091bce227d794a36af2e5dfc4a791efad | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.29e-06 | 168 | 166 | 7 | 03896466698a79f7f1ad862cb7e05585260e2a5a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.56e-06 | 170 | 166 | 7 | adb625124832b0786a590e8f75b61e7263a1e0d4 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.56e-06 | 170 | 166 | 7 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-06 | 171 | 166 | 7 | ab21f20ec041cbaacccbd7da4dccdb77ec8bc5c6 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-06 | 171 | 166 | 7 | 97ad2cfff568a9d006ab1d2e6e00946ee4e3beb3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.99e-06 | 173 | 166 | 7 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_NK|GI_small-bowel / Manually curated celltypes from each tissue | 5.00e-06 | 179 | 166 | 7 | 535bdfdd990ba9ee3edc8f3ad15297f8fb5a266e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.18e-06 | 180 | 166 | 7 | d9dae9db8e17f6990032ee6cfa8393fae4768ca5 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.99e-06 | 184 | 166 | 7 | 6e17c8151d6dc543de16d804db956c63c3fda414 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.99e-06 | 184 | 166 | 7 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.89e-06 | 188 | 166 | 7 | 9b95730ddd13eb4624321bab3ab4989414977ca3 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.13e-06 | 189 | 166 | 7 | a59025e82fabd9d60e2438dee85b2644478cc7c8 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 7.13e-06 | 189 | 166 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.13e-06 | 189 | 166 | 7 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|COPD / Disease state, Lineage and Cell class | 7.38e-06 | 190 | 166 | 7 | 006e31606d637033bc81333816ee332773d36b08 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.64e-06 | 191 | 166 | 7 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 192 | 166 | 7 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 192 | 166 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.90e-06 | 192 | 166 | 7 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.90e-06 | 192 | 166 | 7 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | wk_08-11-Epithelial-PNS-KCNIP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.90e-06 | 192 | 166 | 7 | 53642c88891f4e4e14b1740c5ced759b7d8b3572 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.18e-06 | 193 | 166 | 7 | 194b49c152e3e3f599068ec88a7f0af6427b743a | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 8.46e-06 | 194 | 166 | 7 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 194 | 166 | 7 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.46e-06 | 194 | 166 | 7 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.46e-06 | 194 | 166 | 7 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | RA-08._Macrophage|RA / Chamber and Cluster_Paper | 8.46e-06 | 194 | 166 | 7 | ac26e5c71d5069622de72fa25a9c920887ac2c19 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 8.74e-06 | 195 | 166 | 7 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 195 | 166 | 7 | 10ce1b6961f10372d1f65388cbf3626a5fcd6840 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 195 | 166 | 7 | 42bfdff88da1d07828c0ad65d412fb1752f0cee4 | |
| ToppCell | Control-Myeloid|Control / Disease state, Lineage and Cell class | 8.74e-06 | 195 | 166 | 7 | 46ce2e403ca5d757e5ba17349b6c7ce5cde1f195 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.74e-06 | 195 | 166 | 7 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.04e-06 | 196 | 166 | 7 | a44a648bf209ce037bfc7b3adfcb220aab60728c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.04e-06 | 196 | 166 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.04e-06 | 196 | 166 | 7 | cacd69be72e6167814f7adea7c5fa114f3103bbb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.04e-06 | 196 | 166 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.04e-06 | 196 | 166 | 7 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-06 | 197 | 166 | 7 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-06 | 197 | 166 | 7 | 0523aec9713ae21e6b879aa98e07fa2576610d5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-06 | 197 | 166 | 7 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-06 | 197 | 166 | 7 | 826cc6baafab13e7ef5cfcf28cd79d0fbf3af38d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-06 | 197 | 166 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-06 | 197 | 166 | 7 | 61ef3f417767c3f5296a26399da63e3e4f58faf8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-06 | 197 | 166 | 7 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-06 | 197 | 166 | 7 | 6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.35e-06 | 197 | 166 | 7 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.35e-06 | 197 | 166 | 7 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.35e-06 | 197 | 166 | 7 | 8b9a88fb671d5c2b25d291c851e2b8a478f2610c | |
| ToppCell | healthy_donor-Lymphocytic-T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 9.35e-06 | 197 | 166 | 7 | 63d0f06e150e7eb800ecb70e97b9d12a01c84e37 | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.66e-06 | 198 | 166 | 7 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | PBMC-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 9.66e-06 | 198 | 166 | 7 | fb873b7636bb1c7b119dd5b23d7a20f518e6c6da | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-06 | 198 | 166 | 7 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.66e-06 | 198 | 166 | 7 | 00a54af5267bfe0eeab6720bf890dc4b6b803bfd | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 9.66e-06 | 198 | 166 | 7 | 2e470249edc7cf85bed550795ff84cbef22895c0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.66e-06 | 198 | 166 | 7 | 623f9d64c9e800d2d7f623392bf2f22b563f0249 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.98e-06 | 199 | 166 | 7 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.98e-06 | 199 | 166 | 7 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.98e-06 | 199 | 166 | 7 | fde8e3ba19d19069a4d3b8db55bfe6220cf634d5 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid-Microglia|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 9.98e-06 | 199 | 166 | 7 | 4ddfbcaa8054b69b3398d8c0d5fab8ae94805cb9 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 8.15e-07 | 177 | 168 | 10 | 4652_DN | |
| Drug | forskolin; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 2.60e-06 | 157 | 168 | 9 | 913_UP | |
| Drug | Vistar | 6.46e-06 | 36 | 168 | 5 | CID000040896 | |
| Drug | mag-fura-2 | 7.42e-06 | 37 | 168 | 5 | CID000123839 | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.33e-05 | 192 | 168 | 9 | 7427_DN | |
| Drug | Diperodon hydrochloride [537-12-2]; Up 200; 9.2uM; HL60; HG-U133A | 1.51e-05 | 195 | 168 | 9 | 1575_UP | |
| Drug | hydantoin-5-propionic acid | 1.55e-05 | 21 | 168 | 4 | CID000000782 | |
| Disease | factor VIII measurement, venous thromboembolism | 1.11e-06 | 34 | 161 | 5 | EFO_0004286, EFO_0004630 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 6.97e-06 | 23 | 161 | 4 | EFO_0004286, EFO_0004791 | |
| Disease | platelet crit | FLI1 ST3GAL4 JAK2 ZGPAT TGM3 THBS1 ARHGEF40 SVIL NECTIN2 SYK RCOR3 RP1 GAPDHS PLEK FYB1 ATP2B4 SORL1 | 1.92e-05 | 952 | 161 | 17 | EFO_0007985 |
| Disease | factor XI measurement, venous thromboembolism | 2.09e-05 | 30 | 161 | 4 | EFO_0004286, EFO_0004694 | |
| Disease | Syndactyly Cenani Lenz type | 2.96e-05 | 2 | 161 | 2 | C1859309 | |
| Disease | Stuve-Wiedemann syndrome | 2.96e-05 | 2 | 161 | 2 | cv:C0796176 | |
| Disease | cortical thickness | THSD4 FLII DCDC1 ASIC2 PRSS12 STRBP LAMA2 ME2 RIT2 THBS1 VPS13D ARHGEF40 ALX1 VCAN LRP4 SYT1 AKAP10 USP35 | 3.97e-05 | 1113 | 161 | 18 | EFO_0004840 |
| Disease | Acute Myeloid Leukemia, M1 | 6.60e-05 | 125 | 161 | 6 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 6.60e-05 | 125 | 161 | 6 | C1879321 | |
| Disease | Malignant neoplasm of breast | COL19A1 PCDHGB6 STRBP PDZK1 OBSCN LAMA2 GRB7 THBS1 NSUN6 ARAP3 SIPA1L1 NECTIN2 DIP2C AKT1 HOXB13 GOLGB1 SORL1 | 8.54e-05 | 1074 | 161 | 17 | C0006142 |
| Disease | Schwartz-Jampel syndrome | 8.84e-05 | 3 | 161 | 2 | cv:C0036391 | |
| Disease | interleukin-6 receptor subunit beta measurement | 8.84e-05 | 3 | 161 | 2 | EFO_0801732 | |
| Disease | Schizophrenia | PDZK1 APC LAMA2 LASP1 CSMD2 NRN1 ME2 CHRNA3 ADCY7 SYNGAP1 LIFR THBS1 GLO1 AKT1 NKAPL | 1.05e-04 | 883 | 161 | 15 | C0036341 |
| Disease | urate measurement | DCDC1 PDZK1 ASH1L DNAH1 THBS1 HOXD13 NECTIN2 RBM6 LRP4 SYT1 FLRT1 FAIM2 UBE2W KLC1 KLB | 1.22e-04 | 895 | 161 | 15 | EFO_0004531 |
| Disease | Coloboma of lens | 1.76e-04 | 4 | 161 | 2 | C0344516 | |
| Disease | cutaneous leishmaniasis (is_implicated_in) | 1.76e-04 | 4 | 161 | 2 | DOID:9111 (is_implicated_in) | |
| Disease | Coloboma of eyelid | 1.76e-04 | 4 | 161 | 2 | C0521573 | |
| Disease | Congenital myotonia | 1.76e-04 | 4 | 161 | 2 | cv:CN295225 | |
| Disease | Congenital coloboma of iris | 2.93e-04 | 5 | 161 | 2 | C0266551 | |
| Disease | Coloboma of optic disc | 2.93e-04 | 5 | 161 | 2 | C0155299 | |
| Disease | odorant-binding protein 2b measurement | 2.93e-04 | 5 | 161 | 2 | EFO_0801859 | |
| Disease | Coloboma of choroid and retina | 2.93e-04 | 5 | 161 | 2 | C4708599 | |
| Disease | bacterial gastritis (is_marker_for) | 2.93e-04 | 5 | 161 | 2 | DOID:4033 (is_marker_for) | |
| Disease | Hereditary macular coloboma | 2.93e-04 | 5 | 161 | 2 | C1852767 | |
| Disease | hepatocellular carcinoma (biomarker_via_orthology) | 3.22e-04 | 108 | 161 | 5 | DOID:684 (biomarker_via_orthology) | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 3.55e-04 | 239 | 161 | 7 | EFO_0010934 | |
| Disease | creatinine measurement | DCDC1 OBSCN LAMA2 STAC2 NFATC1 SVIL AP3B2 NECTIN2 DIP2C SYT1 RCOR3 TOMM40 FAIM2 SLC23A2 SORL1 | 3.79e-04 | 995 | 161 | 15 | EFO_0004518 |
| Disease | Leukemia, Myelocytic, Acute | 3.87e-04 | 173 | 161 | 6 | C0023467 | |
| Disease | Rheumatoid Arthritis | 3.99e-04 | 174 | 161 | 6 | C0003873 | |
| Disease | right ventricular ejection fraction measurement | 5.81e-04 | 30 | 161 | 3 | EFO_0021816 | |
| Disease | Prostatic Neoplasms | PDZK1 ASH1L APC GRB7 JAK2 LIFR NECTIN2 AKT1 ALOX5 HOXB13 IL6ST | 5.96e-04 | 616 | 161 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | PDZK1 ASH1L APC GRB7 JAK2 LIFR NECTIN2 AKT1 ALOX5 HOXB13 IL6ST | 5.96e-04 | 616 | 161 | 11 | C0376358 |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 6.10e-04 | 7 | 161 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | immunoglobulin superfamily containing leucine-rich repeat protein 2 measurement | 6.10e-04 | 7 | 161 | 2 | EFO_0021879 | |
| Disease | Polysyndactyly | 6.10e-04 | 7 | 161 | 2 | C0265553 | |
| Disease | stomach cancer (is_implicated_in) | 6.58e-04 | 72 | 161 | 4 | DOID:10534 (is_implicated_in) | |
| Disease | cesarean section, anxiety | 8.11e-04 | 8 | 161 | 2 | EFO_0005230, EFO_0009636 | |
| Disease | Syndactyly | 8.11e-04 | 8 | 161 | 2 | C0039075 | |
| Disease | serum alanine aminotransferase measurement | IL32 ARHGAP39 ATP10D ZGPAT THBS1 MORF4L1 NECTIN2 RBM6 TOMM40 RP1 USP35 HEPHL1 ALOX5 | 1.00e-03 | 869 | 161 | 13 | EFO_0004735 |
| Disease | Mental deterioration | 1.04e-03 | 9 | 161 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 1.04e-03 | 9 | 161 | 2 | C1270972 | |
| Disease | visceral leishmaniasis (is_implicated_in) | 1.04e-03 | 9 | 161 | 2 | DOID:9146 (is_implicated_in) | |
| Disease | hepatocyte growth factor-like protein measurement | 1.17e-03 | 38 | 161 | 3 | EFO_0008154 | |
| Disease | free cholesterol in medium LDL measurement | 1.36e-03 | 40 | 161 | 3 | EFO_0022268 | |
| Disease | depressive symptom measurement, response to antidepressant | 1.39e-03 | 88 | 161 | 4 | EFO_0007006, GO_0036276 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 1.57e-03 | 42 | 161 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | pulmonary tuberculosis (is_implicated_in) | 1.57e-03 | 42 | 161 | 3 | DOID:2957 (is_implicated_in) | |
| Disease | concentration of large LDL particles measurement | 1.79e-03 | 44 | 161 | 3 | EFO_0022160 | |
| Disease | cholesterol in medium VLDL measurement | 1.79e-03 | 44 | 161 | 3 | EFO_0022225 | |
| Disease | cerebral amyloid deposition measurement | 1.85e-03 | 95 | 161 | 4 | EFO_0007707 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.88e-03 | 12 | 161 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of salivary gland | 1.91e-03 | 45 | 161 | 3 | C0220636 | |
| Disease | total lipids in small LDL | 2.17e-03 | 47 | 161 | 3 | EFO_0022168 | |
| Disease | Salivary Gland Neoplasms | 2.17e-03 | 47 | 161 | 3 | C0036095 | |
| Disease | free cholesterol in small VLDL measurement | 2.17e-03 | 47 | 161 | 3 | EFO_0022272 | |
| Disease | free cholesterol in medium VLDL measurement | 2.17e-03 | 47 | 161 | 3 | EFO_0022269 | |
| Disease | Cakut | 2.22e-03 | 13 | 161 | 2 | C1968949 | |
| Disease | Familial Alzheimer Disease (FAD) | 2.23e-03 | 100 | 161 | 4 | C0276496 | |
| Disease | Adenoid Cystic Carcinoma | 2.23e-03 | 100 | 161 | 4 | C0010606 | |
| Disease | Alzheimer's Disease | 2.31e-03 | 101 | 161 | 4 | C0002395 | |
| Disease | pancreatic cancer (is_marker_for) | 2.31e-03 | 101 | 161 | 4 | DOID:1793 (is_marker_for) | |
| Disease | physical activity measurement | 2.33e-03 | 245 | 161 | 6 | EFO_0008002 | |
| Disease | complement factor H-related protein 3 measurement | 2.40e-03 | 169 | 161 | 5 | EFO_0600056 | |
| Disease | phospholipids in medium LDL measurement | 2.44e-03 | 49 | 161 | 3 | EFO_0022183 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 2.44e-03 | 49 | 161 | 3 | EFO_0021897 | |
| Disease | cholesterol in medium LDL measurement | 2.44e-03 | 49 | 161 | 3 | EFO_0022224 | |
| Disease | cholesterol in small LDL measurement | 2.44e-03 | 49 | 161 | 3 | EFO_0022227 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.44e-03 | 49 | 161 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Impaired cognition | 2.58e-03 | 14 | 161 | 2 | C0338656 | |
| Disease | free cholesterol in LDL measurement | 2.59e-03 | 50 | 161 | 3 | EFO_0022266 | |
| Disease | free cholesterol in large LDL measurement | 2.74e-03 | 51 | 161 | 3 | EFO_0022176 | |
| Disease | phospholipids in IDL measurement | 2.90e-03 | 52 | 161 | 3 | EFO_0022164 | |
| Disease | total lipids in medium LDL | 2.90e-03 | 52 | 161 | 3 | EFO_0022180 | |
| Disease | total lipids in LDL measurement | 2.90e-03 | 52 | 161 | 3 | EFO_0022308 | |
| Disease | phospholipids in large LDL measurement | 3.06e-03 | 53 | 161 | 3 | EFO_0022174 | |
| Disease | cholesterol in small VLDL measurement | 3.06e-03 | 53 | 161 | 3 | EFO_0022228 | |
| Disease | free cholesterol in small LDL measurement | 3.06e-03 | 53 | 161 | 3 | EFO_0022271 | |
| Disease | Autistic Disorder | 3.18e-03 | 261 | 161 | 6 | C0004352 | |
| Disease | pancreatic cancer (is_implicated_in) | 3.36e-03 | 112 | 161 | 4 | DOID:1793 (is_implicated_in) | |
| Disease | vitamin C measurement | 3.38e-03 | 16 | 161 | 2 | EFO_0600003 | |
| Disease | congenital myasthenic syndrome (implicated_via_orthology) | 3.38e-03 | 16 | 161 | 2 | DOID:3635 (implicated_via_orthology) | |
| Disease | digit length ratio | 3.38e-03 | 16 | 161 | 2 | EFO_0004841 | |
| Disease | Polyposis, Adenomatous Intestinal | 3.38e-03 | 16 | 161 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 3.38e-03 | 16 | 161 | 2 | C2713443 | |
| Disease | pneumonia, COVID-19 | 3.47e-03 | 113 | 161 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | total lipids in large LDL | 3.76e-03 | 57 | 161 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 3.76e-03 | 57 | 161 | 3 | EFO_0021901 | |
| Disease | Carcinoma, Granular Cell | 3.81e-03 | 116 | 161 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.81e-03 | 116 | 161 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.81e-03 | 116 | 161 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.81e-03 | 116 | 161 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.81e-03 | 116 | 161 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 3.81e-03 | 116 | 161 | 4 | C0001418 | |
| Disease | heart disease (biomarker_via_orthology) | 3.81e-03 | 17 | 161 | 2 | DOID:114 (biomarker_via_orthology) | |
| Disease | ulcerative colitis (is_implicated_in) | 3.81e-03 | 17 | 161 | 2 | DOID:8577 (is_implicated_in) | |
| Disease | Adenomatous Polyposis Coli | 3.81e-03 | 17 | 161 | 2 | C0032580 | |
| Disease | HMG CoA reductase inhibitor use measurement | 3.87e-03 | 189 | 161 | 5 | EFO_0009932 | |
| Disease | venous thromboembolism | 3.88e-03 | 460 | 161 | 8 | EFO_0004286 | |
| Disease | cholesterol in IDL measurement | 3.95e-03 | 58 | 161 | 3 | EFO_0021899 | |
| Disease | phospholipids in LDL measurement | 3.95e-03 | 58 | 161 | 3 | EFO_0022294 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KSPPSKNSDFYMGAG | 11 | Q15699 | |
| KDGATMKTFCGTPEY | 301 | P31749 | |
| YCTSPDFKMGGASDV | 526 | Q9NR48 | |
| SKLKGPEGGSEMFVY | 1301 | Q8TER5 | |
| FTYPKGAGEMLEDGS | 36 | Q96DE5 | |
| SLMYFGSDKDPFPKG | 316 | Q8WWN8 | |
| APKNGMVFGKEYTVG | 2536 | Q7Z408 | |
| KMGKAGVRTYGFRSP | 221 | P13611 | |
| SDYGGAEFMRVPAQK | 101 | P32297 | |
| TYAGKMTFGRVSDLG | 581 | O43572 | |
| EDGKMIPASQYFSTG | 316 | Q3SY69 | |
| SAMDKDSGPNGQLDY | 2691 | Q6V0I7 | |
| YGDINGFSAMAKTVG | 861 | Q9UDR5 | |
| GIVGAKSPYVDDMGA | 1066 | Q5VU97 | |
| PSGVVMEGYLFKRAS | 266 | Q96P50 | |
| EGYMEKTGPKQTEGF | 256 | O75689 | |
| MPAKGRYFLNEGEEG | 1 | P51828 | |
| GEMEKSRRYGAPSSA | 326 | P54253 | |
| NPNGGFRMYSKGASE | 581 | P23634 | |
| DQGYSETKAFEMAGP | 1406 | Q9P241 | |
| MDKGQRDPYSGNAFL | 36 | Q5SZJ8 | |
| DMNYIASSGPLFKDG | 146 | Q9BYT9 | |
| MSAAPAYSEDKGGSA | 1 | Q13367 | |
| MRGTGNKSTDGAYKP | 116 | Q9HBZ2 | |
| GKCYMFNSGEDGKPL | 191 | Q16515 | |
| MSYPTKEGSDTAGNA | 1 | Q8N123 | |
| FGSKAPGPAMYERVS | 136 | Q6P1R3 | |
| DDGGYTPDLKMSYSR | 131 | P0DJD3 | |
| DDGGYTPDLKMSYSR | 131 | A6NDE4 | |
| DDGGYTPDLKMSYSR | 131 | P0DJD4 | |
| DDGGYTPDLKMSYSR | 131 | P0C7P1 | |
| DDGGYTPDLKMSYSR | 131 | A6NEQ0 | |
| DDGGYTPDLKMSYSR | 131 | Q15415 | |
| PGATKYTDKDNGGML | 16 | Q9P2K3 | |
| YKPFGKEAAGTMTLS | 56 | Q96IZ5 | |
| LGVKSGDYSTMEGPE | 441 | Q9C0H5 | |
| GKGNFGSVEMCRYDP | 856 | O60674 | |
| PSYKGDASDPKAAGM | 321 | Q14573 | |
| PYFSLMVRVNSDGGK | 176 | Q9Y5F9 | |
| PRIVEMKKGSNGYGF | 241 | Q5T2W1 | |
| EQYAEGKMRGAAPGK | 121 | Q9UBU8 | |
| SGLQGGPRSDFDMAY | 426 | Q8IY17 | |
| EGFSPSGAKMYIQGV | 376 | M0R2J8 | |
| PARARTMAYFGEGKG | 546 | P56730 | |
| EETYKKFSGAMDGAP | 21 | Q9H2Z4 | |
| KGGYFPENVKAMTSL | 21 | Q13045 | |
| PSYEEATSGEGMKAG | 36 | Q9BWQ8 | |
| NASPGGSEENKRAYM | 1586 | Q86YW9 | |
| DSGGPIFKSPQTYMD | 2831 | Q16787 | |
| FSYGQKPYRGMKGSE | 566 | P43405 | |
| SGEPMDKAGGYGIQA | 166 | O95671 | |
| SSKPYGPYDRGSDMK | 461 | O43451 | |
| KYHEEFEKSRMGPSG | 121 | Q14847 | |
| NYEAYKPSTGAMGDR | 681 | Q86XP3 | |
| YLTKDGPFLMVGDAA | 196 | Q6X9E4 | |
| GKMKGLAFIQDPDGY | 156 | Q04760 | |
| SGHKYGPEDKENMSR | 191 | Q9Y6X5 | |
| MAKYNTGGNPTEDVS | 1 | O15117 | |
| PRAGGTMKSAEEEHY | 31 | O95644 | |
| MTGDKGPQRLSGSSY | 1 | P49279 | |
| GDSMANYPQGLDDKT | 46 | Q9NPD7 | |
| GCMGETYFDNKPIGL | 2301 | P24043 | |
| KYGDPGSLFGFSLAM | 36 | P23229 | |
| MEAAGSPAATETGKY | 1 | Q9BRP8 | |
| MELFRIGGKSPDTNY | 66 | P62714 | |
| IGGKSPDTNYLFMGD | 71 | P62714 | |
| MELFRIGGKSPDTNY | 66 | P67775 | |
| IGGKSPDTNYLFMGD | 71 | P67775 | |
| YAPGIVSASQFMKAG | 131 | Q8TEA1 | |
| MRKTEEPGKFSAYGG | 81 | Q9NY56 | |
| VTQGRKLYGMPTDFG | 286 | Q14451 | |
| FTSDMAYVINGGDKP | 1236 | O00750 | |
| AGPKYEMRSQGATRE | 4111 | Q5VST9 | |
| MRKTEEPGKYSAYGG | 81 | Q9NPH6 | |
| GALAGSEGTAYSPKM | 306 | P15863 | |
| EYKEGVGKFIGMPES | 76 | Q9H974 | |
| GRTSTADYAMFKVGP | 281 | P02679 | |
| KSGGAMAAGDYPEAS | 546 | Q13467 | |
| GDFMSPGSDVKSYEL | 2516 | Q9P2D7 | |
| MVVYDPDKGSNGTFL | 391 | Q9BYE9 | |
| MSSFQSYGAPRGDKE | 206 | P24001 | |
| RMAAYTDEGGKDGPE | 591 | P40189 | |
| SNAPGSGTEKRKAMY | 331 | Q96JJ3 | |
| AGEPGKYDSMARKGD | 716 | Q14993 | |
| GEPVGDDYKKMGTLF | 61 | Q8N8J7 | |
| PPSFGYSMKGATDID | 431 | P06756 | |
| YSMKGATDIDKNGYP | 436 | P06756 | |
| KADMTASGSPDYGQP | 31 | Q01543 | |
| GFPVEKYMDVSGLAS | 161 | P35453 | |
| NVFSYEMDGPEGSTK | 286 | Q7Z4T8 | |
| VLMKAGSAPVDAGGY | 251 | Q9NTQ9 | |
| RTAPKYGNAELMETG | 231 | Q9Y2E4 | |
| GDGTYGSVLMGKSNE | 11 | P20794 | |
| YGQLGTGDKMDRGEP | 386 | O75426 | |
| LYPDGTSGRNKNDDM | 141 | Q6MZM0 | |
| GTDNIALLKDPFYMG | 206 | P23368 | |
| GDGDYPEGMRKKLFS | 336 | Q86Z14 | |
| KDMTGKEDNYRGPAV | 111 | Q9Y678 | |
| FDLSQGGPKEALEMY | 326 | Q13574 | |
| SNIDYPMATGDGAKT | 396 | Q9NZU1 | |
| PGKESLGYFVGVDMD | 256 | Q9NQC7 | |
| AAAKGPMAGILAYTE | 336 | O14556 | |
| MEPGNYATLDGAKDI | 1 | Q92826 | |
| AESGDSVKMYGSAVP | 796 | O95104 | |
| KNGSGELSYGEVMGP | 351 | Q9Y467 | |
| GPRFKKLADMYGGDD | 771 | Q9ULB4 | |
| KYESGPDGGEEVSMS | 531 | Q07866 | |
| LRAYTDGGVGPEKSM | 811 | P42702 | |
| MPGGSVKDQLKAYGA | 446 | Q99759 | |
| FPSDGYGVDQTSMNK | 1281 | P56715 | |
| LPVGYEAEMSSKGAG | 796 | Q2WGJ9 | |
| PEGQDYLKGMAAAGN | 301 | Q9Y3I0 | |
| ALDMGGTSDPYVKVF | 171 | P21579 | |
| RNLKAMDIGGTSDPY | 291 | O43581 | |
| NFTGKAEMGGPFSYV | 186 | Q9BVX2 | |
| GEMPKFDGAGYDKDL | 176 | Q9BW62 | |
| SQMFGYGQSKSFPEG | 416 | P78332 | |
| GDLKPGIYRSNMDGS | 896 | Q92673 | |
| MYGASGGRAKPERKS | 1 | Q12872 | |
| SSVVKGRFMGDPSYE | 96 | Q9H1X1 | |
| GEGPYDMVFQKGDSV | 231 | O75716 | |
| LTGRDSGMEKYGSFE | 956 | O95425 | |
| MVVFGYEAGTKPRDS | 1 | Q8IUX1 | |
| YGMRGRKSSGFPKSV | 516 | P09917 | |
| PGSASGGSREYKVVM | 11 | Q99578 | |
| GAGKTYTMEGTAENP | 531 | Q9BVG8 | |
| SPSSFVDKGMSYIVG | 301 | Q86UY8 | |
| NEGYLQPAGDMSKSA | 186 | P08567 | |
| KMEAYGGQLGSFPTS | 461 | Q96SF7 | |
| LYSQGSKGPGEDFRM | 131 | P41222 | |
| SKGPGEDFRMATLYS | 136 | P41222 | |
| IYGGDGLDPAAMEGK | 901 | O14802 | |
| SVGGTYRQKSMPEGF | 1161 | O43166 | |
| PVAGYEGDVGSKTTM | 151 | Q11206 | |
| EGDVGSKTTMRLFYP | 156 | Q11206 | |
| GSDPATYNGFLEIMK | 56 | O75182 | |
| KVLQAMGYPTGFDAD | 446 | Q96SI9 | |
| KVDPAGRYFAGTMAE | 106 | Q15493 | |
| LAFMDLGYSTTVGPK | 66 | Q8NH51 | |
| VYYDPMGNPLDKGSD | 311 | Q08188 | |
| DGYGKRGQMKPSIES | 971 | P25054 | |
| GKSPDYANGGKAAMD | 61 | Q8NCQ2 | |
| FKIYRTEMAPGASQG | 206 | Q96DZ9 | |
| SLIMKPREDGSSGNY | 766 | P98196 | |
| LPGEGAAMAEYVKAG | 301 | Q5M9Q1 | |
| ASKDGQPYDMGGSAK | 611 | O94762 | |
| TPTKTYGMGKGRAAD | 91 | O60701 | |
| AAGYDGKAFGSPMID | 596 | O15164 | |
| IMADSGPIYDKTYAG | 1131 | P07996 | |
| RRKSVPGGKQYSMEG | 106 | Q96PV0 | |
| GNKSLDGMESYNLPF | 591 | Q9UGH3 | |
| PYSFTPMLEEGAGSK | 116 | Q8N2H3 | |
| MYAKGGKGSAVPSDS | 1 | Q9BWG4 | |
| PFSGNKEQGYMSLKE | 361 | Q6ZMT1 | |
| DGPGMTAASGKLYQF | 61 | Q5TAB7 | |
| AGFYPRLMAKSDTGK | 426 | Q9P2H5 | |
| GMKPNTLVLGFYDDA | 621 | Q9BXP2 | |
| KDKVAMAPDGNGGLY | 216 | Q3KQV9 | |
| DMDGYLGETSAGPGK | 266 | Q9Y279 | |
| CETENPMGGYGKTIS | 141 | Q9Y265 | |
| GFNTKMADGPDEYDT | 6 | Q8IUH5 | |
| PGEEGTVMSLAGKYT | 241 | O96008 | |
| MDPLGGSDTAKGYNL | 261 | Q99536 | |
| GAVPKGNATKEYMES | 106 | Q9NXF8 | |
| MEGAPGTLYEGEKFQ | 41 | Q96B02 | |
| EGGGTMFTYKRPNEI | 476 | Q6ZMP0 | |
| YGGEMVSVSASFDGK | 156 | Q8N228 | |
| KIMRDPDTGNSKGYA | 131 | Q15427 | |
| EAGAAPAGRRSKDMY | 431 | Q8N5A5 | |
| SQNGFGYKMPDVPDA | 216 | Q8NEZ2 | |
| AFDTRYAGQKTSPGM | 2341 | Q5THJ4 | |
| SSGLKQNYDEMSPAG | 956 | Q14789 | |
| KSKFTDPGMGNLTYS | 1751 | O75096 | |
| PSDSYQGKGFVMSRA | 521 | Q92692 |